The Food and Drug Administration this week issued guidance intended to clarify the agency’s expectations when electronic health records are used as a source of data in clinical investigations. The guidance applies to clinical investigations of human drugs and biological products, medical devices and combination products, including investigations conducted in clinical practice settings.

Related News Articles

AHA Center for Health Innovation Market Scan
Amazon has introduced a new cloud-based software service that reportedly will sift through patient medical records in seconds searching for actionable…
Letter
Public
Joint letter from AHA and six other national hospital associations to HHS affirming hospital and health system commitment to interoperability, while stating…
Letter
Public
Letter
Public
Download the comment letter (PDF)
Advisory
Member
The Centers for Medicare & Medicaid Services (CMS) Aug.
Press Releases